Companies: 10,795·Total market cap: $144.5T
ProPhase Labs, Inc.

ProPhase Labs, Inc.

PRPHNASDAQHealthcare● Active
$0.10
$-0.01(-9.09%)
Market Cap$473701
P/E Ratio
52W High$6.7
52W Low$0.07
Overview

ProPhase Labs, Inc. (PRPH) Revenue

Annual & quarterly revenue history · segment & region breakdown

PRPH · revenue · updated Jun 9, 2026

Core revenue metrics

ProPhase Labs, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 35.82% year-over-year from $0.00B in FY2025.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
-35.82%
vs FY2025 $0.00B
Price / sales
0.11×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$45K
96 employees
FY2025
$0.00B
FY2024
$0.01B
5Y CAGR
+-44.0%
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · ProPhase Labs, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

20252006 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-12-31$0.00B-$0.00B-35.82%
2024-12-31$0.01B-$0.04B-84.75%
2023-12-31$0.04B-$0.08B-63.81%
2022-12-31$0.12B+$0.04B+55.17%
2021-12-31$0.08B+$0.06B+444.59%
2020-12-31$0.01B+$0.00B+46.96%
2019-12-31$0.01B-$0.00B-24.76%
2018-12-31$0.01B+$0.00B+33.03%
2017-12-31$0.01B-$0.01B-53.05%
2016-12-31$0.02B+$0.00B+1.99%
PRPH revenue by year · PRPH revenue history · PRPH annual revenue data

Revenue breakdown

Segment & Geography
By business segment
Total$0.00B
$0.00B100.0%
By geography
No segment data available for this period.
Data from ProPhase Labs, Inc. annual 10-K filing · FY ending 2025-12-31
PRPH revenue breakdown · PRPH revenue by segment · PRPH revenue by region

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income ProPhase Labs, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

ProPhase Labs, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from ProPhase Labs, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

PRPH revenue · 4 questions

PRPH's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 35.82% year-over-year from $0.00B in FY2025.

PRPH revenuePRPH annual revenuewhat is PRPH revenuePRPH TTM revenue

Source: FMP · ProPhase Labs, Inc. SEC filings · GAAP · ProPhase Labs, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026